Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.020
+0.035 (1.76%)
Nov 3, 2026, 4:08 PM HKT
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.1 billion as of November 2, 2026. It is the 22,862nd most valuable company in the world and the 1,082nd biggest in Hong Kong. Its market cap has decreased by 35.16% in one year.
Market Cap
1.10B
Enterprise Value
586.33M
Revenue
40.41M
Global Rank
Country Rank
#1,082 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.10B, a decrease of -85.58%. That is a compound annual growth rate of -29.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.10B | -31.87% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 1.55B |
| SinoMab BioScience | 1.48B |
| Beijing Biostar Pharmaceuticals | 1.32B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.25B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |
| TYK Medicines | 1.19B |
| Cloudbreak Pharma | 1.10B |
| CANbridge Pharmaceuticals | 1.06B |